Nouveau Logo communiqué de presse.JPG
Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth
12 sept. 2022 07h30 HE | Theratechnologies
Researchers report superior anticancer activity against cancer stem-like cells with TH1902, compared to unconjugated docetaxelFirst evidence for TH1902 targeting of human breast and ovarian cancer...
Nouveau Logo communiqué de presse.JPG
L’étude sur le TH1902 de Theratechnologies publiée dans la revue Pharmaceutics montre une inhibition de la croissance des cellules de type souches cancéreuses humaines du cancer de l’ovaire et du CSTN exprimant le récepteur de la sortiline (SORT1) et de la croissance tumorale
12 sept. 2022 07h30 HE | Theratechnologies
Les chercheurs signalent une activité anticancéreuse supérieure contre les cellules de type souches cancéreuses avec le TH1902, comparativement au docétaxel non conjugué.Premières données probantes...
Featured Image for Experimental Biology and Medicine
New Study Finds Mouse Embryonic Stem Cells Have No Special Requirement for Threonine
07 sept. 2022 10h00 HE | Experimental Biology and Medicine
WASHINGTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 15, August, 2022) challenges that mouse embryonic stem cells are...
logo 600X600.png
Global Cell Cryopreservation Market to Surpass US$ 43,546.4 Million by 2030, Says Coherent Market Insights (CMI)
18 août 2022 09h10 HE | CMI
Seattle, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global cell cryopreservation market is estimated to be valued at US$ 8,659.4 million in 2022 and is expected to...
With 12.8% CAGR, Stem Cells Market Size worth USD 27.65 Billion in 2028
06 juil. 2022 08h29 HE | Fortune Business Insights
Pune, India, July 06, 2022 (GLOBE NEWSWIRE) -- The global stem cells market size is expected to gain momentum by reaching USD 27.65 billion by 2028. Fortune Business Insights in its latest report,...
GoodCell Offers Pers
GoodCell Offers Personal Biobanking Early Adopter Discount for a Limited Time
13 juin 2022 07h00 HE | GoodCell
Waltham, MA, June 13, 2022 (GLOBE NEWSWIRE) -- Today, GoodCell, a life sciences company, is announcing a limited-time early adopter discount for Personal Biobanking, a proactive, preventative...
Kevin R. Stone, MD, conducting a cartilage regeneration experiment for Stone Research Foundation
California Stem Cell Agency Awards the Stone Research Foundation $1.3M to Fight Osteoarthritis
01 févr. 2022 15h19 HE | The Stone Research Foundation
SAN FRANCISCO, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Kevin R. Stone, MD, Orthopaedic Surgeon and Chairman of the Stone Research Foundation, and Mani Vessal, Ph.D., Sr. Director of Research and...
C3i_Center larger res.png
C3i Center Inc. Secures CAP Accreditation, Launches New Lab Spinoff
09 nov. 2021 10h00 HE | Centre C3i Inc.
MONTRÉAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- C3i Center Inc. has strengthened our position as Canada’s leading one-stop contract development and manufacturing organization operating in the cell...
visiongain Logo.png
Global Stem Cell Technologies Market is projected to be worth US$ 21.03 Billion by 2031: Visiongain Research Inc
27 oct. 2021 07h58 HE | Visiongain Ltd
Visiongain Published Global Stem Cell Technologies & Applications Market Report 2021-2031. Value Forecasts by Type (Allogenic, and Autologous), by Product (Adult Stem Cells, Human Embryonic Stem...
Cryo-Cell International, Inc. logo
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
15 oct. 2021 16h36 HE | Cryo-Cell International, Inc.
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...